Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Hyperthermia Enhances Radiation Therapy for Cervical Cancer

By HospiMedica staff writers
Posted on 18 Feb 2004
A hyperthermia system has been shown to be a powerful component in more-effective cancer therapy, including radiation therapy for cervical cancer.

A phase III clinical trial has demonstrated that when hyperthermia was added to radiation in treating advanced cervical cancer, complete tumor response jumped from 57% for the patient control group receiving radiation alone to 83% for those receiving both radiation and hyperthermia. More...
In the same study, the three-year survival rate nearly doubled for those patients who received both radiation and hyperthermia.

The hyperthermia system used in the trial was the BSD-2000, which delivers microwave energy to cancerous tumors, including those located deep within the body, such as gynecologic cancers. During treatment, the patient is placed in a prone position on a specially designed support, and an applicator containing an array of microwave antennae is place around the patient's body. The BSD then focuses and delivers microwave energy on the tumor using a model provided through treatment planning and system software that precisely steers microwave energy on the target. Hyperthermia therapy both kills cancer cells directly and oxygenates cancerous tumors so that radiation beams can more effectively form the oxygen radicals required to attack and destroy cancer cell DNA.

The BSD-2000 is the product of BSD Medical Corp. (Salt Lake City, UT, USA). The company has just announced the installation of a new BSD-2000 hyperthermia system at the Bad Trissl Clinic in Oberaudorf (Germany), which specializes in the treatment of gynecologic cancer.




Related Links:
BSD Medical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.